Global Molecular Diagnostics Market: Opportunities & Future Forecast
09/22/2009 included "Global Molecular Diagnostics Market: Opportunities & Future Forecast" report that forecasts the global molecular diagnostics market in 2011

Online PR News – 22-September-2009 – – Global Molecular Diagnostics Market: Opportunities & Future Forecast

The report titled “Global Molecular Diagnostics Market: Opportunities & Future Forecast” analysis the global molecular diagnostics market. This research report provides the global molecular diagnostics industry past present and future scenario. The specific clinical segments like Infectious Disease Testing Market, ID/forensics Market, Tissue Typing Market, Oncology Market, Food Testing Market, Genetic Testing Market and Pharmacogenomics Market past, present and future scenario has been analyzed in this report. The report provides separate comprehensive past, present and future forecast of molecular diagnostics market on country level as well. Countries covered in the report are: US, Europe and India. (

Market Overview

Based on its exceptional ability to accurately detect the primary cause of disease, molecular diagnostics has emerged as the fastest growing segment of the in vitro diagnostics (IVD) industry. Growing with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 7 Billion by 2011. The infectious disease was having the biggest market share of 70 percent but gradually its share will decline to 50 percent. The future growth is expected to come from Oncology Testing, Genetic Testing and Pharmacogenomics Testing.

Geographically, the US and European markets are the most advanced in terms of adoption of molecular testing and make up the majority of the existing market. However Indian molecular diagnostics market is also catching up fast and future growth is expected from these markets when US and European market will mature. Key player wise molecular diagnostics market is dominated by big companies such as Roche Diagnostics, Gen-Probe, Siemens Healthcare Diagnostics Inc. and Abbott Laboratories which are active in every segment of the clinical diagnostics market. They have broader product portfolios, which can address the needs of any kind of clinical laboratories. However, their leadership is likely to be challenged by the emergence of a new breed of players who target growth areas such as oncology and pharmacogenomics.

For more information please visit:

Contact us at:
Bharat Book Bureau
Tel: 91 22 27578668
Fax: 91 22 27579131